Novartis AG (NYSE: NVS) on Tuesday reported Gilenya sales were $273 million. In the view of analyst Brian Abrahams, sales ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE